← back to search

Claus Wittekindt

Witten/Herdecke University · DE
Area of research
Otorhinolaryngology · Surgery
Research interest
Research interests include Head and Neck Cancer Studies, Salivary Gland Tumors Diagnosis and Treatment, Esophageal Cancer Research and Treatment, and Head and Neck Surgical Oncology.
h-index
43
citations
4,955
works
269
NIH funding
primary concept
Medicine
email

Recent publications

Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis
The Lancet Oncology 2023cited by 275position: middledoi
Predicting HPV association using deep learning and regular H&E stains allows granular stratification of oropharyngeal cancer patients
npj Digital Medicine 2023cited by 21position: middledoi
Predictors for Survival of Patients with Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region
Cancers 2023cited by 6position: lastdoi
Correction: Evaluation of p16INK4a expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation
British Journal of Cancer 2021cited by 3position: middledoi
Correction: Evaluation of p16<sup>INK4a</sup> expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation.
2021cited by 1position: contributordoi
Evaluation of p16INK4a expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation
British Journal of Cancer 2020cited by 60position: middledoi
Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&amp;E Stains
Clinical Cancer Research 2020cited by 56position: middledoi
Evaluation of p16<sup>INK4a</sup> expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation.
2020cited by 38position: contributordoi
Increasing Incidence rates of Oropharyngeal Squamous Cell Carcinoma in Germany and Significance of Disease Burden Attributed to Human Papillomavirus
Cancer Prevention Research 2019cited by 103position: firstdoi
Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer
International Journal of Cancer 2019cited by 47position: middledoi
Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC).
Journal of Clinical Oncology 2019cited by 3position: middledoi
[Value of sialendoscopy in German ENT-hospitals in 2016].
2019cited by 0position: contributordoi
Reply to ‘Comment on ‘Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer”
British Journal of Cancer 2018cited by 0position: middledoi
Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer
British Journal of Cancer 2017cited by 66position: middledoi
CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma
International Journal of Cancer 2015cited by 93position: middledoi
Employment pathways and work‐related issues in head and neck cancer survivors
Head & Neck 2014cited by 70position: middledoi
p16<sup>INK4a</sup>/Ki‐67 co‐expression specifically identifies transformed cells in the head and neck region
International Journal of Cancer 2014cited by 51position: middledoi
Updated S2K AWMF Guideline for the Diagnosis and Follow-up of Obstructive Sialadenitis – Relevance for Radiologic Imaging
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 2014cited by 22position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jens Peter Klußmann · Düsseldorf University Hospital14 papers (2014–2023)Steffen Wagner · Justus-Liebig-Universität Gießen12 papers (2014–2023)Magnus von Knebel Doeberitz · Hospital Sírio-Libanês11 papers (2014–2023)Elena‐Sophie Prigge · German Cancer Research Center9 papers (2014–2023) · 7 papers (2015–2023)Nora Wuerdemann · Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde7 papers (2017–2023) · 6 papers (2017–2023)Shachi Jenny Sharma · Centrum für Integrierte Onkologie5 papers (2017–2023)Miriam Reuschenbach · MSD (Germany)4 papers (2014–2018) · 3 papers (2019–2021) · 3 papers (2015–2021) · 3 papers (2020–2023)Hans Christian Reinhardt · Düsseldorf University Hospital2 papers (2020–2023) · 2 papers (2015–2019)Alexander Quaas · Heinrich Heine University Düsseldorf2 papers (2020–2023) · 2 papers (2017–2018)Christoph Arens · University Hospital Heidelberg2 papers (2023–2023) · 2 papers (2020–2023) · 2 papers (2020–2021) · 2 papers (2020–2023)